450 related articles for article (PubMed ID: 28283099)
1. Sensitivity of visual evoked potentials and spectral domain optical coherence tomography in early relapsing remitting multiple sclerosis.
Behbehani R; Ahmed S; Al-Hashel J; Rousseff RT; Alroughani R
Mult Scler Relat Disord; 2017 Feb; 12():15-19. PubMed ID: 28283099
[TBL] [Abstract][Full Text] [Related]
2. Optimization of spectral domain optical coherence tomography and visual evoked potentials to identify unilateral optic neuritis.
Behbehani R; Ali A; Al-Omairah H; Rousseff RT
Mult Scler Relat Disord; 2020 Jun; 41():101988. PubMed ID: 32092503
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
Esen E; Sizmaz S; Balal M; Yar K; Demirkiran M; Unal I; Demircan N
Curr Eye Res; 2016 Oct; 41(10):1353-1358. PubMed ID: 26882356
[TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.
Behbehani R; Abu Al-Hassan A; Al-Salahat A; Sriraman D; Oakley JD; Alroughani R
PLoS One; 2017; 12(2):e0172120. PubMed ID: 28192539
[TBL] [Abstract][Full Text] [Related]
5. Optical coherence tomography and visual evoked potential and its relationship with neurological disability in patients with relapsing-remitting multiple sclerosis.
Piedrabuena R; Bittar M
Mult Scler Relat Disord; 2022 Jan; 57():103420. PubMed ID: 34906813
[TBL] [Abstract][Full Text] [Related]
6. Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.
Laron M; Cheng H; Zhang B; Schiffman JS; Tang RA; Frishman LJ
Mult Scler; 2010 Apr; 16(4):412-26. PubMed ID: 20207786
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of axonal optic nerve damage using visual evoked potentials and optical coherence tomography in patients with multiple sclerosis.
Pastare D; Kire I; Erts R; Laganovska G; Millers A
Medicina (Kaunas); 2013; 49(11):474-8. PubMed ID: 24823928
[TBL] [Abstract][Full Text] [Related]
8. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.
Pueyo V; Martin J; Fernandez J; Almarcegui C; Ara J; Egea C; Pablo L; Honrubia F
Mult Scler; 2008 Jun; 14(5):609-14. PubMed ID: 18424482
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography versus visual evoked potentials in detecting subclinical visual impairment in multiple sclerosis.
Grecescu M
J Med Life; 2014; 7(4):538-41. PubMed ID: 25713617
[TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
Di Maggio G; Santangelo R; Guerrieri S; Bianco M; Ferrari L; Medaglini S; Rodegher M; Colombo B; Moiola L; Chieffo R; Del Carro U; Martinelli V; Comi G; Leocani L
Mult Scler; 2014 Sep; 20(10):1342-7. PubMed ID: 24591532
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis.
Naismith RT; Tutlam NT; Xu J; Shepherd JB; Klawiter EC; Song SK; Cross AH
Neurology; 2009 Jul; 73(1):46-52. PubMed ID: 19564583
[TBL] [Abstract][Full Text] [Related]
12. Relationship between optical coherence tomography and electrophysiology of the visual pathway in non-optic neuritis eyes of multiple sclerosis patients.
Sriram P; Wang C; Yiannikas C; Garrick R; Barnett M; Parratt J; Graham SL; Arvind H; Klistorner A
PLoS One; 2014; 9(8):e102546. PubMed ID: 25166273
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of retinal nerve fibre layer thickness and visual evoked potentials in optic neuritis associated with multiple sclerosis.
Chatziralli IP; Moschos MM; Brouzas D; Kopsidas K; Ladas ID
Clin Exp Optom; 2012 Mar; 95(2):223-8. PubMed ID: 22329676
[TBL] [Abstract][Full Text] [Related]
14. Color vision testing versus pattern visual evoked potentials and optical coherence tomography parameters in subclinical optic nerve involvement in multiple sclerosis.
Yuksel B; Dogan B; Koctekin B; Atis N; Erdal A; Kurtulus F; Erol MK; Gomceli YB
J Clin Neurosci; 2019 Mar; 61():48-53. PubMed ID: 30455132
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Pattern Reversal and Flash Visual Evoked Potential Latencies With Optical Coherence Tomography Measures in Patients With Optic Neuropathy and Patients With Multiple Sclerosis Without Optic Neuropathy.
Moussa H; Sawaya RA; Deeb R; El Ayoubi N
J Clin Neurophysiol; 2022 Nov; 39(7):637-642. PubMed ID: 33555731
[TBL] [Abstract][Full Text] [Related]
16. Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
Tugcu B; Soysal A; Kılıc M; Yuksel B; Kale N; Yıgıt U; Arpaci B
J Neurol Sci; 2013 Dec; 335(1-2):182-5. PubMed ID: 24148562
[TBL] [Abstract][Full Text] [Related]
17. MS optic neuritis-induced long-term structural changes within the visual pathway.
Pawlitzki M; Horbrügger M; Loewe K; Kaufmann J; Opfer R; Wagner M; Al-Nosairy KO; Meuth SG; Hoffmann MB; Schippling S
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32224498
[TBL] [Abstract][Full Text] [Related]
18. Axonal loss and myelin in early ON loss in postacute optic neuritis.
Klistorner A; Arvind H; Nguyen T; Garrick R; Paine M; Graham S; O'Day J; Grigg J; Billson F; Yiannikas C
Ann Neurol; 2008 Sep; 64(3):325-31. PubMed ID: 18825673
[TBL] [Abstract][Full Text] [Related]
19. Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosis.
González-López JJ; Rebolleda G; Leal M; Oblanca N; Muñoz-Negrete FJ; Costa-Frossard L; Alvarez-Cermeño JC
Biomed Res Int; 2014; 2014():128517. PubMed ID: 25313352
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitations.
Serbecic N; Aboul-Enein F; Beutelspacher SC; Graf M; Kircher K; Geitzenauer W; Brannath W; Lang P; Kristoferitsch W; Lassmann H; Reitner A; Schmidt-Erfurth U
PLoS One; 2010 Nov; 5(11):e13877. PubMed ID: 21079732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
